| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
33,770,000 |
| Market
Cap: |
13.24(M) |
| Last
Volume: |
131,457 |
Avg
Vol: |
131,097 |
| 52
Week Range: |
$0.302 - $1.03 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Strata Skin Sciences is a medical technology company in dermatology. Co. is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. Co.'s products include the XTRAC® and Pharos® excimer lasers and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. The XTRAC and Pharos excimer laser technology emits ultraviolet (UV) light targeted towards autoimmune dermatological skin disorders such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in the same way as the XTRAC.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
20,000 |
1,930,207 |
1,931,257 |
| Total Buy Value |
$0 |
$8,956 |
$1,070,489 |
$1,071,581 |
| Total People Bought |
0 |
1 |
4 |
5 |
| Total Buy Transactions |
0 |
1 |
4 |
5 |
| Total Shares Sold |
0 |
0 |
1,000 |
1,000 |
| Total Sell Value |
$0 |
$0 |
$320 |
$320 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
1 |
1 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bonanza Master Fund Ltd |
10% Owner |
– – • |
2008-06-23 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
1,674,200 |
|
- |
|
| Bonanza Master Fund Ltd |
10% Owner |
– – • |
2008-06-23 |
4 |
S |
$8.09 |
$813,500 |
D/D |
(100,000) |
1,674,200 |
|
- |
|
| Cheng-Avery Tina |
V.P. of Commercialization |
• – – |
2008-05-23 |
4 |
B |
$7.47 |
$62,119 |
I/I |
8,000 |
8,000 |
1.99 |
- |
|
| Castleman Breaux |
Director |
– • – |
2007-12-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
91,070 |
|
- |
|
| Castleman Breaux |
Director |
– • – |
2007-12-05 |
4 |
B |
$4.64 |
$9,280 |
D/D |
2,000 |
93,070 |
2.39 |
- |
|
| Bonanza Master Fund Ltd |
10% Owner |
– – • |
2007-12-04 |
4 |
B |
$4.25 |
$822,375 |
I/I |
193,500 |
1,774,200 |
1.5 |
- |
|
| Bonanza Master Fund Ltd |
10% Owner |
– – • |
2007-12-04 |
4 |
B |
$4.25 |
$822,375 |
D/D |
193,500 |
1,774,200 |
2.45 |
- |
|
| Gulfo Joseph V |
CEO & President |
• • – |
2007-11-30 |
4 |
B |
$4.57 |
$24,160 |
D/D |
5,000 |
10,100 |
2.81 |
- |
|
| Bonanza Capital Ltd |
10% Owner |
– – • |
2007-11-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,580,700 |
|
- |
|
| Bonanza Capital Ltd |
10% Owner |
– – • |
2007-11-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,580,700 |
|
- |
|
| Lufkin Dan W |
Director |
– • – |
2007-11-23 |
4 |
B |
$4.23 |
$35,532 |
D/D |
8,400 |
326,736 |
2.39 |
- |
|
| Lufkin Dan W |
Director |
– • – |
2007-11-14 |
4 |
B |
$4.40 |
$44,000 |
D/D |
10,000 |
318,336 |
2.39 |
- |
|
| Castleman Breaux |
Director |
– • – |
2007-11-14 |
4 |
B |
$4.38 |
$8,760 |
D/D |
2,000 |
94,070 |
2.39 |
- |
|
| Gulfo Joseph V |
CEO & President |
• • – |
2007-11-13 |
4 |
B |
$4.40 |
$21,995 |
D/D |
5,000 |
5,100 |
2.81 |
- |
|
| Chryssis George C |
Director |
– • – |
2007-11-13 |
4 |
B |
$4.40 |
$22,032 |
D/D |
5,000 |
40,000 |
2.39 |
- |
|
| Chryssis George C |
Director |
– • – |
2007-09-18 |
4 |
B |
$5.53 |
$11,290 |
D/D |
2,000 |
35,000 |
2.39 |
- |
|
| Chryssis George C |
Director |
– • – |
2007-09-10 |
4 |
B |
$6.00 |
$6,000 |
D/D |
1,000 |
33,000 |
2.39 |
- |
|
| Chryssis George C |
Director |
– • – |
2007-08-16 |
4 |
B |
$5.60 |
$5,600 |
D/D |
1,000 |
32,000 |
2.39 |
- |
|
| Lufkin Dan W |
Director |
– • – |
2007-06-07 |
4 |
A |
$6.85 |
$34,250 |
I/I |
5,000 |
10,000 |
|
- |
|
| Lufkin Dan W |
Director |
– • – |
2007-06-07 |
4 |
GD |
$6.85 |
$34,250 |
D/D |
5,000 |
303,336 |
|
- |
|
| Cleary Martin D |
Director |
– • – |
2007-06-04 |
4 |
B |
$5.45 |
$5,459 |
I/I |
1,000 |
1,000 |
2.1 |
- |
|
| Chryssis George C |
Director |
– • – |
2007-05-30 |
4 |
B |
$4.95 |
$4,950 |
D/D |
1,000 |
31,000 |
2.31 |
- |
|
| Cleary Martin D |
Director |
– • – |
2007-05-29 |
4 |
B |
$4.60 |
$920 |
D/D |
200 |
5,443 |
2.31 |
- |
|
| Cleary Martin D |
Director |
– • – |
2007-05-25 |
4 |
B |
$4.57 |
$24,018 |
D/D |
5,243 |
5,243 |
2.39 |
- |
|
| Lufkin Dan W |
Director |
– • – |
2007-02-22 |
4 |
A |
$6.85 |
$34,250 |
D/D |
5,000 |
308,336 |
|
- |
|
216 Records found
|
|
Page 7 of 9 |
|
|
0.01 (1.82%) 
